TNF-a antagonist multi-target binding proteins

Details for Australian Patent Application No. 2009266863 (hide)

Owner EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC

Inventors Lofquist, Alan Keith; Mohler, Kendall Mark; Baum, Peter Robert; Thompson, Peter Armstrong; Misher, Lynda

Agent Spruson & Ferguson

Pub. Number AU-A-2009266863

PCT Pub. Number WO2010/003108

Priority 61/134,100 02.07.08 US; 61/134,098 02.07.08 US; 61/134,095 02.07.08 US; 61/134,096 02.07.08 US; 61/180,097 20.05.09 US; 61/134,099 02.07.08 US; 61/134,097 02.07.08 US; 61/134,101 02.07.08 US

Filing date 2 July 2009

Wipo publication date 7 January 2010

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/003108 Priority application(s): WO2010/003108

17 February 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read TNF-alpha antagonist multi-target being proteins

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009266869-Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders

2009266861-Systems and methods for automated muscle stimulation